CD177 and breast carcinoma: CD44 is a cell surface receptor expressed by many cell types, including breast cancer stem cells that interacts with a variety of effectors [17] and initiates many regulatory mechanisms related to adhesion, cell proliferation, migration, invasiveness, and chemo-resistance [18, 19].